Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Nov 20;40(33):3787-3789.
doi: 10.1200/JCO.22.01136. Epub 2022 Jun 27.

Longitudinal Analyses of COVID-19 Vaccination in Patients With Lung Cancer: Antibody Responses and Variant-Specific Neutralization

Philip C Mack  1 , Fred R Hirsch  1 , Paul A Bunn  2 , John D Minna  3
Affiliations
Editorial

Longitudinal Analyses of COVID-19 Vaccination in Patients With Lung Cancer: Antibody Responses and Variant-Specific Neutralization

Philip C Mack et al. J Clin Oncol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

John D. Minna

Stock and Other Ownership Interests: Moderna Therapeutics, Novavax, Johnson & Johnson/Janssen, Qiagen

Research Funding: Regeneron (Inst)

Patents, Royalties, Other Intellectual Property: US National Cancer Institute (NCI) royalties for licensing of human cancer cell lines, University of Texas Southwestern Medical Center Royalties for licensing of human cancer cell lines (Inst), MiNA Therapeutics licensing of technology

No other potential conflicts of interest were reported.

Comment on

References

    1. Garassino MC, Whisenant JG, Huang LC, et al. : COVID-19 in patients with thoracic malignancies (TERAVOLT): First results of an international, registry-based, cohort study. Lancet Oncol 21:914-922, 2020 - PMC - PubMed
    1. Lee LY, Cazier JB, Angelis V, et al. : COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: A prospective cohort study. Lancet 395:1919-1926, 2020 - PMC - PubMed
    1. Lièvre A, Turpin A, Ray-Coquard I, et al. : Risk factors for coronavirus disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19). Eur J Cancer 141:62-81, 2020 - PMC - PubMed
    1. Tagliamento M, Agostinetto E, Bruzzone M, et al. : Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast cancers: A systematic review and meta-analysis. Crit Rev Oncol Hematol 163:103365, 2021 - PMC - PubMed
    1. Ganti AK, Fillmore N, La J, et al. : Factors associated with severe COVID-19 infections in lung cancer patients. J Thorac Oncol 16:S921-S922, 2021